HGHRX
Price
$35.31
Change
+$0.32 (+0.91%)
Updated
Apr 2 closing price
Net Assets
887.25M
JFNIX
Price
$67.97
Change
+$0.80 (+1.19%)
Updated
Apr 2 closing price
Net Assets
4.95B
Ad is loading...

HGHRX vs JFNIX

Header iconHGHRX vs JFNIX Comparison
Open Charts HGHRX vs JFNIXBanner chart's image
Hartford Healthcare R3
Price$35.31
Change+$0.32 (+0.91%)
VolumeN/A
Net Assets887.25M
Janus Henderson Global Life Sciences I
Price$67.97
Change+$0.80 (+1.19%)
VolumeN/A
Net Assets4.95B
HGHRX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGHRX vs. JFNIX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a StrongBuy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.95B vs. HGHRX (887M). JFNIX pays higher dividends than HGHRX: JFNIX (0.39) vs HGHRX (0.00). HGHRX was incepted earlier than JFNIX: HGHRX (18 years) vs JFNIX (16 years). HGHRX (1.62) is less costly to investors than JFNIX (0.77). HGHRX has a lower initial minimum investment than JFNIX: HGHRX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -6.45 vs. HGHRX (-10.28). JFNIX return over 5 years is better than : 35.56 vs. HGHRX (7.93).
HGHRXJFNIXHGHRX / JFNIX
Total Expense Ratio1.620.77210%
Annual Report Gross Expense Ratio1.620.77210%
Fund Existence18 years16 years-
Gain YTD-1.270-0.0741,728%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets887M4.95B18%
Annual Yield % from dividends0.000.39-
Returns for 1 year-10.28-6.45159%
Returns for 3 years-9.842.72-361%
Returns for 5 years7.9335.5622%
Returns for 10 years-12.5019.64-64%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMCX6.950.10
+1.46%
Royce Micro-Cap Consult
APDRX31.200.24
+0.78%
Artisan Global Opportunities Advisor
OTCHX26.72N/A
N/A
MFS Mid Cap Growth R3
BINCX19.56N/A
N/A
Brandes International Small Cap Equity C
BGEAX30.91N/A
N/A
Brandes Global Equity A